Steve Donoghue work email
- Valid
Steve Donoghue personal email
- Valid
Trained as a scientist with specialism in neuro and cardiovascular physiology, subsequently worked in academia (4 years) then (for 25+ years) in the pharmaceutical industry. I am a highly experienced drug development expert who has led clinical development and global project teams for many drug development programmes through to regulatory approval and an experienced manager of large teams of staff.I am now a self-employed consultant providing strategic and operational expertise to the healthcare industry - my specific areas of expertise are drug development strategy from first into man to marketing approval, clinical operations, general management and clinical development. Currently I am Vice President Clinical research at Curelator Inc. which develops digital platforms to improve management of a range of chronic conditions.
Self-Employed
-
Clinical Research ConsultantSelf-Employed Jul 2013 - PresentUnited Kingdom
-
Vice President Clinical ResearchCurelator Inc. Jun 2013 - PresentFirst use of Curelator technology is in (self) management of migraine via an App (to collect daily lifestyle and headache data) and proprietary analytical analysis of individual's data to produce a 'trigger map' and to propose tests of behavioural modifications to improve management of the condition. The platform will subsequently be developed for other chronic conditions characterised by attacks or relapses.I direct the clinical aspects of product development and the clinical testing programme which is ongoing: see curelator.com for more information.
-
OwnerDaffodil Consulting Llp May 2006 - Jun 2013United KingdomDaffodil Consulting provides strategic and operational services to pharmaceutical and biotech companies, on drug and device development and commercialisation. Personally I provide services regarding clinical research, project management/leadership, preparation of MAAs and general management.Current main role:VP Clinical Development, Curelator Inc. Previous major assignments:1) VP Clinical Development, Genmedica Therapeutics, Spain2) VP Operations, Sarah Cannon Research UK -
Vp Clinical ResearchElan Pharmaceuticals 1995 - 2006As Vice President Clinical Research, Europe I was responsible for all aspects of clinical research outside the USA. Therapeutic areas included neurology, pain treatment and gastrointestinal diseases and multiple products were succesfully developed and brought to market. -
Vp Clinical DevelopmentElan 1995 - 2006
-
Vp Clinical Development And Head European DevelopmentElan Pharma Ltd 2001 - 2005
-
Senior Clinical Research ManagerGlaxo R&D Sep 1987 - Jul 1995Senior Manager/Team Leader - sumatriptan phase 2/3 clinical trials, Europe. Sumatriptan was the first in class of the triptans for treatment of migraine attacks.Clinical Project Leader - Diabetes (troglitazone) clinical trials.
-
Senior Clinical Research ManagerGlaxosmithkline 1987 - 1995
Steve Donoghue Skills
Frequently Asked Questions about Steve Donoghue
What company does Steve Donoghue work for?
Steve Donoghue works for Self-Employed
What is Steve Donoghue's role at the current company?
Steve Donoghue's current role is Clinical Research Consultant.
What is Steve Donoghue's email address?
Steve Donoghue's email address is st****@****aol.com
What skills is Steve Donoghue known for?
Steve Donoghue has skills like Clinical Development, Clinical Trials, Pharmaceutical Industry, Drug Development, Clinical Research, Biotechnology, Neurology, Oncology, Cro, Life Sciences, Pain Management, Diabetes.
Not the Steve Donoghue you were looking for?
-
1hotmail.co.uk
-
-
-
1hotmail.co.uk
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial